ABOUT SIMR
Company Profile
Management Team
SAB
Vision & Mission
Milestones
Investors
R&D
Research Focus
Pipeline
Translational Center
MEDIA
Expanded Access Policy
Press Releases
PARTNER
Business Development
Research Cooperation
JOIN US
CONTACT
中文
|
EN
ABOUT SIMR
Company Profile
Management Team
SAB
Vision & Mission
Milestones
Investors
R&D
Research Focus
Pipeline
Translational Center
MEDIA
Expanded Access Policy
Press Releases
PARTNER
Business Development
Research Cooperation
JOIN US
CONTACT
中文
EN
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Home
>
ABOUT SIMR
>
Milestones
>
2021
2021
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
18
2022-11
In December, SR419, the Company's first innovative drug to e
In December, SR419, the Company's first innovative drug to enter the clinical stage, was approved by the US Food and Drug Administration (FDA) for its international multi-center Phase II clinical ...
18
2022-11
In October, it completed the B+ round financing of nearly RM
In October, it completed the B+ round financing of nearly RMB200 million led by Zhang Jiang Haocheng and Zhang Jiang Haoheng...
18
2022-11
In October, the second drug candidate, SR1375, successfully
In October, the second drug candidate, SR1375, successfully completed its first dose group administration in Australia....
18
2022-11
In July, the China IND application for SR419, SIMR Biotech's
In July, the China IND application for SR419, SIMR Biotech's first analgesic candidate, was approved by the implied license...
18
2022-11
In February,SIMR Biotech Advisory Board (SAB) was establishe
In February,SIMR Biotech Advisory Board (SAB) was established with the appointment of four internationally well-knowed pain experts....
Road
1
page
5
strip
Road
1
page
5
strip
